Voloridge Investment Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-483,369
| Closed | -$178M | – | 1221 |
|
|
2024
Q4 | $178M | Buy |
483,369
+294,323
| +156% | +$123M | 0.63% | 15 |
|
|
2024
Q3 | $98.3M | Sell |
189,046
-31,480
| -14% | -$16.8M | 0.36% | 57 |
|
|
2024
Q2 | $119M | Buy |
220,526
+96,064
| +77% | +$50.8M | 0.44% | 42 |
|
|
2024
Q1 | $64.5M | Buy |
124,462
+60,909
| +96% | +$30.3M | 0.24% | 111 |
|
|
2023
Q4 | $30M | Sell |
63,553
-296,334
| -82% | -$137M | 0.12% | 226 |
|
|
2023
Q3 | $157M | Buy |
359,887
+59,041
| +20% | +$26.8M | 0.77% | 5 |
|
|
2023
Q2 | $134M | Buy |
300,846
+186,067
| +162% | +$85.8M | 0.63% | 16 |
|
|
2023
Q1 | $52.8M | Buy |
+114,779
| New | +$54.6M | 0.26% | 99 |
|
|
2022
Q4 | – | Sell |
-38,753
| Closed | -$17.6M | – | 1485 |
|
|
2022
Q3 | $17.6M | Buy |
+38,753
| New | +$18.5M | 0.09% | 285 |
|
|
2022
Q1 | – | Sell |
-5,650
| Closed | -$2.62M | – | 1452 |
|
|
2021
Q4 | $2.62M | Sell |
5,650
-233,154
| -98% | -$98.1M | 0.01% | 963 |
|
|
2021
Q3 | $89M | Buy |
238,804
+186,907
| +360% | +$71M | 0.57% | 16 |
|
|
2021
Q2 | $19.8M | Buy |
51,897
+49,488
| +2,054% | +$18.9M | 0.14% | 188 |
|
|
2021
Q1 | $865K | Sell |
2,409
-41,499
| -95% | -$13.3M | 0.01% | 1064 |
|
|
2020
Q4 | $14.1M | Sell |
43,908
-273,117
| -86% | -$83.8M | 0.12% | 208 |
|
|
2020
Q3 | $85.2M | Buy |
317,025
+291,084
| +1,122% | +$78.3M | 0.71% | 18 |
|
|
2020
Q2 | $6.82M | Buy |
+25,941
| New | +$6.92M | 0.08% | 281 |
|
|
2020
Q1 | – | Sell |
-2,095
| Closed | -$633K | – | 1166 |
|
|
2019
Q4 | $633K | Sell |
2,095
-83,656
| -98% | -$23M | 0.01% | 772 |
|
|
2019
Q3 | $20.6M | Buy |
85,751
+72,922
| +568% | +$20M | 0.36% | 38 |
|
|
2019
Q2 | $3.62M | Sell |
12,829
-32,929
| -72% | -$9M | 0.1% | 218 |
|
|
2019
Q1 | $13.1M | Buy |
45,758
+43,374
| +1,819% | +$12.5M | 0.4% | 50 |
|
|
2018
Q4 | $626K | Buy |
2,384
+1,402
| +143% | +$386K | 0.03% | 314 |
|
|
2018
Q3 | $269K | Sell |
982
-6,286
| -86% | -$1.63M | 0.01% | 268 |
|
|
2018
Q2 | $1.73M | Sell |
7,268
-222,452
| -97% | -$51.5M | 0.05% | 284 |
|
|
2018
Q1 | $50.5M | Buy |
229,720
+158,342
| +222% | +$37.2M | 1.19% | 12 |
|
|
2017
Q4 | $16.1M | Sell |
71,378
-171,579
| -71% | -$36.5M | 0.35% | 57 |
|
|
2017
Q3 | $46.1M | Buy |
+242,957
| New | +$46.2M | 1.03% | 17 |
|
|
2017
Q1 | – | Sell |
-8,423
| Closed | -$1.21M | – | 539 |
|
|
2016
Q4 | $1.21M | Buy |
+8,423
| New | +$1.13M | 0.03% | 469 |
|
|
2015
Q2 | – | Sell |
-54,387
| Closed | -$8.4M | – | 321 |
|
|
2015
Q1 | $8.4M | Buy |
54,387
+30,298
| +126% | +$4.31M | 0.41% | 73 |
|
|
2014
Q4 | $3.03M | Buy |
24,089
+9,989
| +71% | +$1.23M | 0.18% | 84 |
|
|
2014
Q3 | $1.69M | Sell |
14,100
-3,904
| -22% | -$448K | 0.08% | 75 |
|
|
2014
Q2 | $1.94M | Sell |
18,004
-25,397
| -59% | -$2.62M | 0.19% | 57 |
|
|
2014
Q1 | $4.32M | Buy |
+43,401
| New | +$3.93M | 0.61% | 37 |
|
Other funds holding ELV
Voloridge Investment Management's ELV Position: Q1 2025 in Review
Voloridge Investment Management sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 483,369 shares — an estimated $178M sold.
Voloridge Investment Management first reported a position in ELV in Q1 2014 and held it in 32 quarters. The position peaked at $178M in Q4 2024. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.
- Voloridge Investment Management reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
- Voloridge Investment Management sold 483,369 Elevance Health shares in Q1 2025, an estimated $178M.
- Voloridge Investment Management first reported a position in Elevance Health in Q1 2014 and held it in 32 quarters.
- Voloridge Investment Management's Elevance Health position peaked at $178M in Q4 2024.
- 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.
Based on Voloridge Investment Management's 13F filing for Q1 2025, filed 15 May 2025.